
About Maxelder Pharma Private Limited
Data last updated:
Maxelder Pharma Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2020PTC134028. Its GSTIN is 09AAGCE0671G1ZP (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Beenu Jain and Sanjay Chaturvedi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 801 Ajnara Integrity Raj Nagar Extension, Ghaziabad, Uttar Pradesh, India – 201017.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.41 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹6.75 Lakh (net margin 1.1%) and EBITDA of ₹19.6 Lakh (EBITDA margin 3.1%). Revenue has grown at a compounded annual rate (CAGR) of 90% over three years.
As per MCA filings, the company has open charges of ₹1.09 Cr on record.
For more details, the company can be reached via its website ashleypharmatech.com.
Company details
Contact details
Maxelder Pharma Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its website is ashleypharmatech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressG – 801 Ajnara Integrity Raj Nagar Extension, Ghaziabad, Uttar Pradesh, India – 201017
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Maxelder Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Maxelder Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Maxelder Pharma Private Limited, buy the company report.
Financials of Maxelder Pharma Private Limited
FY 2025 filings availableMaxelder Pharma Private Limited reported revenue of ₹6.41 Cr (up 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 90% over three years, including 28% growth in the latest year. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹19.6 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.75 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maxelder Pharma Private Limited, buy the company report.
Board of directors of Maxelder Pharma Private Limited
Maxelder Pharma has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Beenu Jain Also directs: Peelife Pharmaceuticals Private Limited | Director | 24 Oct 2022 | 4 Years 0 Months | Current |
| Sanjay Chaturvedi | Director | 25 May 2022 | 4 Years 5 Months | Current |
Peer comparison
Maxelder Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lakhanlal Kantilal Brokers Private Limited | ₹6.42 Cr (FY 2025) | 6.0% | Indore, Madhya Pradesh, India | |||
| Lishanth Commosales Private Limited | ₹6.42 Cr (FY 2020) | Kolkata, West Bengal, India | ||||
| Instameta Worldwide Private Limited | ₹6.42 Cr (FY 2024) | -19.0% | Delhi, India | |||
| Judeson Engineering Services Private Limited | ₹6.42 Cr (FY 2025) | 22.0% | Kochi, Kerala, India | |||
| Saraswat Agrocom Private Limited | ₹6.42 Cr (FY 2025) | 137.0% | Raising Nagar, Rajasthan, India | |||
| Maxelder Pharma Private Limitedthis company | ₹6.41 Cr (FY 2025) | ₹6.75 Lakh | 1.1% | 28.0% | Ghaziabad, Uttar Pradesh, India | |
| Auto Donuts Private Limited | ₹6.41 Cr (FY 2024) | 502.0% | Ludhiana, Punjab, India | |||
| Tirupati Textrade Private Limited | ₹6.41 Cr (FY 2018) | 129.0% | Kolkata, West Bengal, India | |||
| Shreesh Enterprises Private Limited | ₹6.41 Cr (FY 2024) | -36.0% | Portblair, Andaman and Nicobar Islands, India | |||
| Vishnu Foot First Private Limited | ₹6.41 Cr (FY 2025) | 34.0% | Bahadurgarh, Haryana, India | |||
| Hanoi Impex Private Limited | ₹6.41 Cr (FY 2025) | 80.0% | Fort Mumbai, Maharashtra, India |
To see the full peer comparison of Maxelder Pharma Private Limited, buy the company report.
Auditor
Maxelder Pharma Private Limited is audited by TUSHAR TAYAL & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| TUSHAR TAYAL & ASSOCIATES | FY 2022 | 028428C |
Shareholding
The shareholding of Maxelder Pharma Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Maxelder Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Jul 2023 | 100756057 | Hdfc Bank Limited | ₹1.09 Cr | Open |
To see the full charge records of Maxelder Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Maxelder Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maxelder Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Maxelder Pharma Private Limited has 1 active EPFO establishment as of Apr 11, 2024.
GST
Maxelder Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCE0671G1ZP | Uttar Pradesh | Active | 11 Nov 2021 |
To see the full GST registrations and return filing status of Maxelder Pharma Private Limited, buy the company report.
Recent activity
Maxelder Pharma Private Limited has 8 board changes on record since 2020: 2 appointments and 6 cessations. The latest: Sanjay Chaturvedi ceased to be Additional Director on 29 Sep 2023.
1 earlier event is in the company report.
Frequently asked questions
Maxelder Pharma is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 September 2020 (6+ years old) and is registered under CIN U51909UP2020PTC134028.
Maxelder Pharma has 2 current directors:
- Beenu Jain - Director
- Sanjay Chaturvedi - Director
The latest financial statements of Maxelder Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Maxelder Pharma is 09AAGCE0671G1ZP, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Maxelder Pharma is U51909UP2020PTC134028. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxelder Pharma was incorporated on 05 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Maxelder Pharma by revenue are Lakhanlal Kantilal Brokers Private Limited, Lishanth Commosales Private Limited, Instameta Worldwide Private Limited, Judeson Engineering Services Private Limited, Saraswat Agrocom Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Sanjay Chaturvedi ceased to be Additional Director on 29 Sep 2023. Munish Kumar Jain ceased to be Director on 07 Nov 2022. Beenu Jain was appointed as Director on 24 Oct 2022. Maxelder Pharma has 8 board changes on record in total.
Maxelder Pharma can be reached through the website ashleypharmatech.com. Its registered office is in Ghaziabad, Uttar Pradesh, India.
The registered office of Maxelder Pharma is at G – 801 Ajnara Integrity Raj Nagar Extension, Ghaziabad, Uttar Pradesh, India – 201017.
Maxelder Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.